Skip to main content
Acta Crystallographica Section F: Structural Biology Communications logoLink to Acta Crystallographica Section F: Structural Biology Communications
. 2016 Feb 19;72(Pt 3):244–250. doi: 10.1107/S2053230X16002107

Crystal structure of recombinant tyrosinase-binding protein MtaL at 1.35 Å resolution

Xuelei Lai a,b, Montserrat Soler-Lopez b, Wangsa T Ismaya c, Harry J Wichers d, Bauke W Dijkstra a,*
PMCID: PMC4774885  PMID: 26919530

The crystal structure of MtaL shows that conformational changes are needed for binding to mushroom tyrosinase and reveals a putative carbohydrate-binding site that may be associated with glycoreceptor activity.

Keywords: tyrosinase, lectin, tyrosinase-binding protein MtaL, carbohydrate binding

Abstract

Mushroom tyrosinase-associated lectin-like protein (MtaL) binds to mature Agaricus bisporus tyrosinase in vivo, but the exact physiological function of MtaL is unknown. In this study, the crystal structure of recombinant MtaL is reported at 1.35 Å resolution. Comparison of its structure with that of the truncated and cleaved MtaL present in the complex with tyrosinase directly isolated from mushroom shows that the general β-trefoil fold is conserved. However, differences are detected in the loop regions, particularly in the β2–β3 loop, which is intact and not cleaved in the recombinant MtaL. Furthermore, the N-terminal tail is rotated inwards, covering the tyrosinase-binding interface. Thus, MtaL must undergo conformational changes in order to bind mature mushroom tyrosinase. Very interestingly, the β-trefoil fold has been identified to be essential for carbohydrate interaction in other lectin-like proteins. Comparison of the structures of MtaL and a ricin-B-like lectin with a bound disaccharide shows that MtaL may have a similar carbohydrate-binding site that might be involved in glycoreceptor activity.

1. Introduction  

Tyrosinase (EC 1.14.18.1) is a binuclear copper-containing enzyme that catalyzes the o-hydroxylation of monophenols to the corresponding o-diphenols and the subsequent conversion of the o-diphenols to the corresponding o-quinones (Burton, 2003; Claus & Decker, 2006). o-Quinones are precursors for the synthesis of melanins, which are pigments that play important roles in the survival of organisms ranging from bacteria and plants to mammals (Kitajima & Moro-oka, 1994; Solomon et al., 1996; Marusek et al., 2006). In mammals, melanin is mostly found in the skin, where it functions in photoprotection against UV radiation. Plants employ o-quinones in modifying and hardening the protective exterior layer of, for instance, seed envelopes, and as agents against invasive organisms. The latter function also occurs in fruits and potatoes and in the fruit bodies of fungi. These examples illustrate that the function of tyrosinase is associated with a response to adverse stress influences from the environment (Land et al., 2004).

Tyrosinase can be isolated from the common button mushroom Agaricus bisporus as a heterotetrameric protein with a total molecular mass of 120 kDa consisting of two H chains (∼43 kDa each) and two L chains (∼14 kDa each) (Strothkamp et al., 1976; Ismaya et al., 2011). The enzyme is produced as an inactive precursor with a molecular mass of 66 kDa, which led to the suggestion that maturation occurs through the proteolytic removal of a ∼20 kDa fragment by either endogenous or pathogen (serine) proteases (Espín & Wichers, 1999). Since the L chain has a molecular mass of 17 kDa, it was initially assumed to be part of the full-length tyrosinase. However, the crystal structure of the H2L2 complex (PDB entry 2y9w; Ismaya et al., 2011) revealed that the L chain is not derived from the tyrosinase precursor, but is the product of a completely different A. bisporus gene, ORF239342, and has a lectin-like fold. Lectin proteins exert their activity by binding to specific glycoreceptors (Pohleven et al., 2012). Remarkably, the L chain is unique to A. bisporus and clusters close to the tyrosinase genes, which suggest that this cofactor is not an artifact from biochemical tyrosinase purification but has a real biological function in the pathways involving tyrosinase in A. bisporus (Weijn et al., 2013). Unfortunately, only a truncated and cleaved form of the ORF239342 product was present in the crystals of mushroom tyrosinase, which precluded firm conclusions on the role of the L subunit as well as its importance for the functioning of the H subunit.

Here, we present the structure of the intact, full-length mushroom tyrosinase-associated lectin-like protein (hereafter called MtaL) at 1.35 Å resolution and show that conformational changes are needed to bind the tyrosinase H subunit. Furthermore, a structural alignment with proteins containing a lectin-like fold reveals a putative carbohydrate-binding site that may be associated with glycoreceptor activity.

2. Materials and methods  

2.1. Cloning, expression and purification  

The gene encoding the L-chain protein was codon-optimized for Escherichia coli and synthesized by Shine Gene Molecular Biotech Inc., Shanghai, People’s Republic of China. The gene was inserted into the pUC57 vector and amplified by the polymerase chain reaction, using L_Nhe1_for (5′-AATTGCTAGCATGGCTCAGGCTCGTAAAATC-3′) and L_Not1Tev_rev (5′-AATTGCGGCCGCTCCCTGAAAATACAAATTCTCAACAGCGAATTTGATACGC-3′) as primers, which introduced NheI and NotI restriction sites (underlined), respectively, and a carboxyl-terminal Tobacco etch virus cleavage site. The generated PCR product was digested with the NheI and NotI restriction endonucleases and the product was purified and ligated into the pET-21d(+) vector digested with the same restriction enzymes. The resulting construct containing the L-chain gene was confirmed by sequencing (Macrogen Inc., Amsterdam, The Netherlands).

For expression, the pET construct was used to transform E. coli BL21 (DE3) cells (Invitrogen) containing an isopropyl β-d-1-thiogalactopyranoside (IPTG)-inducible T7 polymerase gene. Transformants were grown overnight at 310 K in Luria–Bertani medium to an optical density at 600 nm (OD600) of 0.8–1.0 in the presence of 50 µg ml−1 ampicillin. Expression of the recombinant protein was induced by 0.2 mM IPTG at 303 K. The cells were harvested by centrifugation at 6000g for 15 min, resuspended in binding buffer (25 mM Tris–HCl pH 8.0, 150 mM NaCl) and disrupted by sonication on ice by applying 10 s bursts with 10 s cooling intervals for 15 min. After centrifugation at 20 000g for 30 min, the supernatant was collected and filtered through a 0.45 µm pore-size membrane filter. Subsequently, the supernatant was applied onto Ni2+–nitrilotriacetate affinity resin (Ni–NTA, Qiagen) and incubated for 20 min in a cold room. The resin was washed with binding buffer supplemented with 50 mM imidazole. The bound protein was eluted with elution buffer (25 mM Tris–HCl pH 8.0, 150 mM NaCl, 500 mM imidazole) and the His6 tag was removed by overnight incubation at 273 K with TEV protease at a TEV protease:MtaL molar ratio of 1:50. The cleaved sample was concentrated and applied onto a Superdex 200 column (GE Healthcare, Buckinghamshire, England) pre-equilibrated with 25 mM Tris buffer pH 8.0, 50 mM NaCl for a final size-exclusion chromatography purification step. The protein eluted in a single peak corresponding to a molecular weight of ∼17 kDa (Fig. 1 a). The homogeneity of the protein was confirmed by SDS–PAGE (Fig. 1 b). Fractions containing pure protein were pooled and concentrated to ∼20 mg ml−1 for crystallization screening. The purified proteins were stored at 193 K.

Figure 1.

Figure 1

(a) Superdex 200 gel-filtration column chromatogram showing a peak at an apparent molecular mass of ∼17 kDa. (b) SDS–PAGE gel of peak fractions of the gel-filtration chromatography purification step. The left lane contains molecular-mass markers (labelled in kDa).

2.2. Crystallization  

Screening for suitable crystallization conditions was performed with an HTX crystallization robot (EMBL Grenoble, France) using both commercial and home-made crystallization screening solutions. The crystallization screens were set up by mixing 100 nl protein solution and 100 nl reservoir solution in 96-well sitting-drop plates. All crystallization trials were performed at 293 K. The most promising initial crystallization results were obtained in a condition consisting of 0.1 M bis-tris buffer pH 5.5, 2 M ammonium sulfate as a precipitant in the reservoir (Index screen condition No. 3, Hampton Research; Fig. 2 a). This condition was manually optimized by mixing 1 µl protein solution with 1 µl reservoir solution and varying the pH and the ammonium sulfate concentration. Rod-like crystals were obtained from a setup with reservoir solution consisting of 0.1 M bis-tris buffer pH 5.6, 2.1 M ammonium sulfate (Fig. 2 a, bottom).

Figure 2.

Figure 2

(a) Crystallization hit from the HTX crystallization robot (EMBL Grenoble, France) using the sitting-drop vapour-diffusion method. The bottom figure shows the rod-like crystals obtained after optimization. (b) Diffraction pattern of an MtaL crystal. The resolution at the edge of the detector is 1.32 Å and the arrow at the bottom left indicates spots at 1.35 Å resolution.

2.3. Data collection, processing, structure solution and refinement  

The crystals were mounted in a cryo-loop and subsequently flash-cooled in liquid nitrogen. X-ray diffraction data were collected at 100 K on beamline ID29 (wavelength 0.976 Å) at the European Synchrotron Radiation Facility (ESRF), Grenoble, France using a Pilatus 6M-F detector (Dectris) at a distance of 235.10 mm. The monoclinic crystal was rotated through 213° with an oscillation range of 0.05° per frame. The crystal diffracted to a resolution of 1.35 Å (Fig. 2 b). The data set was processed and integrated using XDS (Kabsch, 2010) in combination with SCALA (Evans, 2006) from the CCP4 package (Winn et al., 2011) (Tables 1 and 2). The structure was phased using molecular replacement with Phaser (McCoy et al., 2007) and the structure of the L chain from the mushroom tyrosinase complex (PDB entry 2y9w, chain C; Ismaya et al., 2011) as the search model. Manual rebuilding was performed with Coot (Emsley et al., 2010) and refinement was performed with REFMAC5 (Murshudov et al., 2011). The coordinates and structure factors have been deposited in the PDB with accession code 5eha.

Table 1. Data-collection and processing statistics.

Values in parentheses are for the outer shell.

Diffraction source ID29, ESRF
Wavelength (Å) 0.976
Temperature (K) 100
Space group I121
a, b, c (Å) 56.97, 61.34, 59.05
α, β, γ (°) 90, 108.36, 90
Mosaicity (°) 0.06
Resolution range (Å) 47.01–1.35 (1.42–1.35)
Total No. of observed reflections 168208 (24357)
No. of unique reflections 41973 (6084)
Completeness (%) 99.2 (98.8)
I/σ(I)〉 16.9 (2.7)
R merge 0.038 (0.455)

R merge = Inline graphic Inline graphic, where I i(hkl) is the intensity of an observation, 〈I(hkl)〉 is the mean value for that reflection and the summations are over all equivalents.

Table 2. Structure solution and refinement.

Resolution range (Å) 47.01–1.35
R factor 0.162
Free R factor 0.183
R.m.s.d., bond lengths (Å) 0.027
R.m.s.d., bond angles (°) 2.432
No. of protein atoms 1230
No. of water molecules 219
Average B factor (Å2)
 Protein 21.7
 Water 35.6
Ramachandran analysis
 No. of residues in favoured regions 153
 No. of residues in disallowed regions 0

3. Results and discussion  

3.1. Overall structure of the MtaL protein  

MtaL has a β-trefoil fold consisting of 12 antiparallel β-strands assembled in a cylindrical barrel of six two-stranded sheets (Fig. 3). The full-length structure covers residues Ala4–Val150; no electron density is visible for the first three residues (MAQ) or the extra residues (ENLYFQ) introduced by the TEV cleavage site at the C-terminus. Residues 29–34 (loop β2–β3; Fig. 3), which were not visible in the L chain in the H2L2 complex structure, likely because of proteolytic cleavage (Ismaya et al., 2011), are well defined in the electron density and are not cleaved (Fig. 4 a). Their conformation is stabilized through crystal-packing inter­actions with residues from a symmetry-related molecule (indicated by an asterisk), with hydrogen bonds between Asn30 Nδ2 and Glu103 O∊1*, Asn30 Oδ1 and Glu103 N*, Leu31 N and Glu104 O∊1*, and Ala32 N and Glu104 O∊2* (Fig. 4 b). Nevertheless, the β2–β3 loop is probably intrinsically flexible since in a different crystal structure of MtaL in space group P21 it shows poor density for some residues that are not stabilized by a symmetry-related molecule (data not shown). Whether this loop conformation accounts for a specific interface with the β8–β9 loop from an adjacent MtaL molecule or simply results from an artifact of crystal packing remains unclear.

Figure 3.

Figure 3

Cartoon diagram of the A. bisporus MtaL crystal structure rainbow colour-coded from the N-terminus (blue) to the C-terminus (red) showing the 12 β-­strands adopting a β-trefoil domain organization. The diagram on the right shows the crystal structure rotated by 90° around the vertical axis.

Figure 4.

Figure 4

(a) Electron density of residues 29–34 from the β2–β3 loop and (b) their interactions with a symmetry-related MtaL molecule (highlighted in grey), showing the stabilizing hydrogen bonds. The 2F oF c map is contoured at 1σ and shown as a blue mesh.

3.2. Conformational changes upon binding to mushroom tyrosinase  

The structure of full-length monomeric MtaL is similar to that of the L-chain subunit bound to mushroom tyrosinase in the H2L2 complex that was solved previously (PDB entry 2y9w, chain C; Ismaya et al., 2011), with a Z-score of 25.8 and an r.m.s.d. of 0.9 Å for 136 superimposed Cα atoms. No major conformational differences were observed between the free and tyrosinase-bound L subunits (Fig. 5 a). However, a flexible loop consisting of residues Ala4–Gly14 is rotated by 90° into the core of the protein, preventing solvent exposure of the residues required for specific binding to tyrosinase (Fig. 5 b).

Figure 5.

Figure 5

(a) Superposition of MtaL (orange) with the L chain of the H2L2 complex (green). The cleavage site in the β2–β3 loop and the N- and C-termini are indicated. (b) Close-up of the tyrosinase-binding interface, showing the N-terminal tail of MtaL (red) rotated by about 90° inwards compared with the equivalent N-terminal tail (green) in the H2L2 tyrosinase complex (purple).

3.3. Putative carbohydrate-binding site  

A search for structural homologues using DALI (Holm et al., 2008) revealed that MtaL has the closest structural similarity to the neurotoxin-associated haemagglutinating protein HA33 from Clostridium botulinum, with a Z-score of 16.9, an r.m.s.d. of 1.9 Å for 129 aligned residues and 14% sequence identity (PDB entry 1ybi, chain A; Arndt et al., 2005). MtaL has the highest sequence identity to the ricin-B-like lectin CNL from the basidiomycete Clitocybe nebularis, with 22% sequence identity, a Z-score of 16.5 and an r.m.s.d. of 2.6 Å for 130 aligned residues (PDB entry 3nbe, chain A; Pohleven et al., 2012; Fig. 6 a). The two homologues are both carbohydrate-binding proteins. MtaL also shares structural homology with the sea mussel galectin CGL from Crenomytilus grayanus (PDB entry 5duy, chain A; 8% sequence identity, Z-score of 13.5, r.m.s.d. of 2.4 Å for 122 aligned residues), which is specific for binding GalNAc/Gal-containing carbohydrate moieties, although it does not share sequence homology with other known galectins or lectins (Jakób et al., 2015). Interestingly, a structural alignment of MtaL with CNL with bound α-lactose (PDB entry 3nbd, chain B; Pohleven et al., 2012) shows similar residues in the sugar-binding site (Fig. 6 b). Only two hydroxyl groups, both belonging to the galactosyl moiety of α-lactose, make hydrogen bonds to the CNL protein: the O3 and O4 hydroxyl groups interact with the Asp20 carboxylate, with additional interactions with the Nδ2 atom of Asn38 (O3), the Nδ2 atom of Asn46 (O3) and the main-chain N atom of Gly23 (O4) (Fig. 6 b, bottom right). No stacking interactions with aromatic side chains are present. Notably, the CNL structure in complex with a nonreducing N-acetylgalacto­samine (GalNAc)-containing carbohydrate (LDN; PDB entry 3nbe) shows a similar binding to that of lactose, although one additional hydrogen bond is formed between the O2-bound carbonyl O atom in the acetate group of GalNAc and the hydroxyl O atom of Ser24 (Pohleven et al., 2012). At the equivalent position in MtaL, sufficient space is also available for binding a saccharide. Among the residues that could provide hydrogen-bonding interactions are Asn24 (equivalent to Asp20 in CNL), Asp42 (equivalent to His35) and Ser26 (equivalent to Ser24). Furthermore, loops β2–β3 and β3–β4, which are involved in sugar binding in CNL, could have a similar role in MtaL. In particular, the β3–β4 loop contains a proline residue (Pro46) that must move out of the way to accommodate a sugar molecule, similar to what was observed for its counterpart Pro41 in the lactose-bound CNL structure (Fig. 6 b, bottom left). Movement of the β3–β4 loop would enable Thr45 (equivalent to Asn38 in CNL) to make hydrogen-bonding interactions with the sugar. Nevertheless, extensive crystal-soaking studies to obtain a structure of MtaL with a bound carbohydrate (such as lactose, glucose, raffinose, galactose or sucrose) were unsuccessful. Thus, although it is an attractive hypothesis that MtaL binds carbohydrates like other lectin-like-fold proteins (Arndt et al., 2005), so far no experimental evidence for such a role has been obtained.

Figure 6.

Figure 6

(a) Structure-based sequence alignment of MtaL with the ricin-B-like lectin (CNL; PDB entry 3nbd, chain B), haemagglutinating protein (HA33; PDB entry 1ybi, chain B) and the sea mussel lectin (CGL; PDB entry 5duy, chain A) performed with the SALIGN web server (Braberg et al., 2012). Carbohydrate-binding residues are highlighted in red. (b) Surface representation of a superposition of the MtaL (gold) and ricin-B-like lectin (cyan) crystal structures. The binding of lactose in the CNL carbohydrate-binding pocket is shown as a stick model. A close-up view of the putative MtaL sugar-recognition/binding site based on the CNL structural alignment is shown at the bottom left of the figure. Loops β2–β3 and β3–β4 involved in CNL–sugar binding could also play a similar role in MtaL, where Pro46 in the β3–β4 loop (Pro41 in CNL) must rotate to enable sugar accommodation. The bottom right figure shows the potential sugar-binding residues that could provide hydrogen-bonding interactions: Asn24 (equivalent to Asp20 in CNL), Asp42 (equivalent to His35) and Thr45 (equivalent to Asn38), highlighted in pink and dark blue, respectively.

4. Conclusions  

In conclusion, our findings indicate that MtaL undergoes conformational changes to bind tyrosinase. Whether the proteolytic cleavage of the protruding β2–β3 loop has bio­logical relevance requires further investigation (Espín & Wichers, 1999; Ismaya et al., 2011). Furthermore, MtaL might have a potential carbohydrate-binding site based on structural analyses, although its functional activity remains unclear. Taken together, these results provide insights into the structural mechanisms of tyrosinase recognition by MtaL and shed light on its biological function.

Supplementary Material

PDB reference: MtaL, 5eha

References

  1. Arndt, J. W., Gu, J., Jaroszewski, L., Schwarzenbacher, R., Hanson, M., Lebeda, F. J. & Stevens, R. C. (2005). J. Mol. Biol. 346, 1083–1093. [DOI] [PubMed]
  2. Braberg, H., Webb, B. M., Tjioe, E., Pieper, U., Sali, A. & Madhusudhan, M. S. (2012). Bioinformatics, 28, 2072–2073. [DOI] [PMC free article] [PubMed]
  3. Burton, S. G. (2003). Trends Biotechnol. 21, 543–549. [DOI] [PubMed]
  4. Claus, H. & Decker, H. (2006). Syst. Appl. Microbiol. 29, 3–14. [DOI] [PubMed]
  5. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. [DOI] [PMC free article] [PubMed]
  6. Espín, J. C. & Wichers, H. J. (1999). J. Agric. Food Chem. 47, 3518–3525. [DOI] [PubMed]
  7. Evans, P. (2006). Acta Cryst. D62, 72–82. [DOI] [PubMed]
  8. Holm, L., Kääriäinen, S., Rosenström, P. & Schenkel, A. (2008). Bioinformatics, 24, 2780–2781. [DOI] [PMC free article] [PubMed]
  9. Ismaya, W. T., Rozeboom, H. J., Weijn, A., Mes, J. J., Fusetti, F., Wichers, H. J. & Dijkstra, B. W. (2011). Biochemistry, 50, 5477–5486. [DOI] [PubMed]
  10. Jakób, M., Lubkowski, J., O’Keefe, B. R. & Wlodawer, A. (2015). Acta Cryst. F71, 1429–1436. [DOI] [PMC free article] [PubMed]
  11. Kabsch, W. (2010). Acta Cryst. D66, 125–132. [DOI] [PMC free article] [PubMed]
  12. Kitajima, N. & Moro-oka, Y. (1994). Chem. Rev. 94, 737–757.
  13. Land, E. J., Ramsden, C. A. & Riley, P. A. (2004). Methods Enzymol. 378, 88–109. [DOI] [PubMed]
  14. Marusek, C. M., Trobaugh, N. M., Flurkey, W. H. & Inlow, J. K. (2006). J. Inorg. Biochem. 100, 108–123. [DOI] [PubMed]
  15. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. [DOI] [PMC free article] [PubMed]
  16. Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011). Acta Cryst. D67, 355–367. [DOI] [PMC free article] [PubMed]
  17. Pohleven, J., Renko, M., Magister, Š., Smith, D. F., Künzler, M., Štrukelj, B., Turk, D., Kos, J. & Sabotič, J. (2012). J. Biol. Chem. 287, 10602–10612. [DOI] [PMC free article] [PubMed]
  18. Solomon, E. I., Sundaram, U. M. & Machonkin, T. E. (1996). Chem. Rev. 96, 2563–2606. [DOI] [PubMed]
  19. Strothkamp, K. G., Jolley, R. L. & Mason, H. S. (1976). Biochem. Biophys. Res. Commun. 70, 519–524. [DOI] [PubMed]
  20. Weijn, A., Bastiaan-Net, S., Wichers, H. J. & Mes, J. J. (2013). Fungal Genet. Biol. 55, 42–53. [DOI] [PubMed]
  21. Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

PDB reference: MtaL, 5eha


Articles from Acta Crystallographica. Section F, Structural Biology Communications are provided here courtesy of International Union of Crystallography

RESOURCES